These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19402123)

  • 1. The impact of crown-rump length measurement error on combined Down syndrome screening: a simulation study.
    Salomon LJ; Bernard M; Amarsy R; Bernard JP; Ville Y
    Ultrasound Obstet Gynecol; 2009 May; 33(5):506-11. PubMed ID: 19402123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of bias in crown-rump length measurement at first-trimester screening for trisomy 21.
    Kagan KO; Hoopmann M; Baker A; Huebner M; Abele H; Wright D
    Ultrasound Obstet Gynecol; 2012 Aug; 40(2):135-9. PubMed ID: 22262465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuchal translucency measurement at different crown-rump lengths along the 10- to 14-week period for Down syndrome screening.
    Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
    Prenat Diagn; 2005 May; 25(5):411-6. PubMed ID: 15906410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
    Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
    Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
    Soergel P; Pruggmayer M; Schwerdtfeger R; Muhlhaus K; Scharf A
    Fetal Diagn Ther; 2006; 21(3):264-8. PubMed ID: 16601335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.
    Prats P; Rodríguez I; Comas C; Puerto B
    Prenat Diagn; 2012 Oct; 32(10):927-32. PubMed ID: 22752980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat measurements of nuchal translucency at 11-14 weeks of gestation: when do we need them?
    Salomon LJ; Porcher R; Socolov D; Lamrani H; Ville Y
    Ultrasound Obstet Gynecol; 2013 Dec; 42(6):629-33. PubMed ID: 23576525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of sonographer nuchal translucency measurement performance--central tendency and dispersion.
    Sahota DS; Chen M; Leung TY; Chan LW; Fung TY; Ting YH; Lau TK
    J Matern Fetal Neonatal Med; 2011 Jun; 24(6):812-6. PubMed ID: 21265719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of image magnification in first-trimester screening for Down syndrome by fetal nuchal translucency in Asians.
    Hsu JJ; Chiang CH; Hsieh CC; Hsieh TT
    Prenat Diagn; 2004 Dec; 24(12):1007-12. PubMed ID: 15614833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
    Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal crown-rump length for measuring the nuchal translucency.
    Wax JR; Pinette MG; Cartin A; Blackstone J
    J Clin Ultrasound; 2007; 35(6):302-4. PubMed ID: 17486568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective validation of first-trimester combined screening for trisomy 21.
    Kagan KO; Etchegaray A; Zhou Y; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
    von Kaisenberg CS; Gasiorek-Wiens A; Bielicki M; Bahlmann F; Meyberg H; Kossakiewicz A; Pruggmayer M; Kamin G; Fritzer E; Harris C; Arnold N;
    J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of likelihood ratios of first-trimester nuchal translucency measurements: multiples of median, delta or mixture.
    Sahota DS; Leung TY; Chen M; Chan LW; Fung TY; Lau TK
    Ultrasound Obstet Gynecol; 2010 Jul; 36(1):15-9. PubMed ID: 20503228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The estimation of median nuchal translucency values between 10 and 14 weeks of pregnancy.
    Bestwick JP; Huttly WJ; Wald NJ
    J Med Screen; 2014 Jun; 21(2):110-2. PubMed ID: 24907361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice.
    Stenhouse EJ; Crossley JA; Aitken DA; Brogan K; Cameron AD; Connor JM
    Prenat Diagn; 2004 Oct; 24(10):774-80. PubMed ID: 15503268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
    Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.